DJPIN. . Orphan drug status. Withdrawal of AGM ResolutionsInvex Granted Key European Patent for Exenatidehe’s known for the vend etc like asxcowboy has pointed out. Target our investor community with our suite of Hotcopper Advertising opportunities. Latest Posts. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. ASX - General. Toubani Resources is an exploration and development company with a focus on developing a gold platform in West Africa. . Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself,Publication of Invex IIH Phase II Pressure Trial Results. IXC Price at posting: 79. you post every single trade that is a sell onto Hotcopper. Market . My understanding is that NEU went from around $1. HotCopper has news, discussion, prices and market data on IXUP LIMITED. Created with Sketch. Created with Sketch. , page-3. Hi Hot Copper, this will be a master thread for my daily posting of the Pharma Market Watchlist, please only keep commentary to the watchlist. 69KBThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. Forgot Client ID or Password? If you're a CommBank customer, you can access CommSec from Netbank. Created with Sketch. Been. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. 91%) As of 03:35PM EST. Most bio's get acquired on P2 readouts, if results are strong early here. Latest Posts. ASX - By Stock. Created with Sketch. Join the HotCopper ASX share market forum today for free. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. 1. The IXC stock may trade low due to this wider macroeconomic issues, but the business itself is top 5% to its peers merely from the fact of having no future funding requirements and that if the trial is a success having close to immediate revenues and default alive status via Peptron manufacturing contract fulfilling demand on potential FDA. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. ASX - Day TradingI sold around half my shares yesterday at 25c. ASX - By Stock. Also took placement stock @$1. ASX - Day Trading. Last updated 10. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. Created with Sketch. Forums. . Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumUK R&D Tax Rebate. Invex Receives Approval for Paediatric Plan from the EMA, page-2. 392 10/12/19 20:43 Post #: 41898691 Share @FullMoonFever Another chart request if you are up for it please thanks in advance IXC Valuation Report MST. ASX - By Stock. . Created with Sketch. Invex Granted Type C Meeting with FDA, page-2. Created with Sketch. . ASX - Day Trading. 50%. Created with Sketch. Created with Sketch. 9 more clinical sites to be rapidly activated in a country with a growing incidence of IIH cases. . ASX - By Stock. Created with Sketch. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. Invex to Present at Virtual ASX Small and Mid-Cap ConferenceHealth & BiotechMay 24, 2020|Tim BorehamSHAREFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a. ASX - Day TradingAs thread states post your questions here and let’s start compiling a list. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. . Trading HaltIXC Valuation Report MST. . . Issue of Tranche 1 Placement Shares and Appendix 2A. Latest Posts. Notification of cessation of securities - IXC. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. ASX - Day TradingCreated with Sketch. Advertise on HotCopper. 59). A rolling snowball gathers snow as it falls down the hill . Created with Sketch. . Company has options because they have cash. , page-5. Daily bounced well off support and now slowly creeping upId like to see a range develop now between say 18 - 23 before next bit of news, page-517. Top 20 remains holding 58% compared to 58. . Forums. ASX - By Stock. 5¢ Sentiment: Buy Disclosure: Held Ive compared IXC to NEU before and believe we approx. Advertise. Invex Therapeutics Lists on ASX, page-3. . 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. 147,415. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. , page-2. But lets not talk about NSB here, we are here to see progress with IXC. Charts. Share "Online registration will open 30 minutes before the Meeting. Market . Forums. 0¢ Sentiment: Buy Disclosure: Held. IXC – iShares Global Energy ETF – Check IXC price, review total assets, see historical growth, and review the. . 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. boolish Jellyroll hey. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. Created with Sketch. Notice of Annual General Meeting/Proxy Form, page-2. IXC Price at posting:. That is fair and as I mentioned in my initial post when buying, the business is worth the cash in ST. INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC IXC chart IXC invex therapeutics ltd IXC chart 1 Last ralom 17,015 Posts. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. ASX - Day TradingAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Umbrella Society is a proud Living Wage Employer! Greater Victoria's official living wage has been adjusted to $25. ASX - Short Term Trading. . View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. A handy 10 bags from here with seemingly little risk. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. ASX - Day TradingWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. ASX - By Stock. ASX - By Stock. 1950. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Created with. Posted without a title, my bad hahaI was going for something like Invex - How much is it worth, when Phase 2 results hit in March 2020?Got this from IXC by email today. . 0. Share Appreciate the commentary and post. ASX - Day TradingTo name a few other biotechs that have gotten belted by the market of the last few months that have had decent bounces such as NOX, NYR and PEB. 0. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. . 0¢ Sentiment: Buy Disclosure: Held. , page-5. Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. 1956773. June 15 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES WRITTEN RESPONSE FROM FDA ON TYPE C MEETING ON PHASE III CLINICAL TRIAL DESIGN FOR. Sentiment for Invex Therapeutics Ltd. , page-6. Last edited by ejjwj: 28/06/23. 38 Biotechnology stocks are valued based on a risk. . Ceasing to be a substantial holder. Charts. But posts 3-4 times a day that are the same charts we can all see, about a -3% move on $10k volume, paired with hysteria and paranoia, its just not. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Join the HotCopper ASX share market. . Of course, IXC’s BoD need to win back credibility for the market to more fairly value IXC’s TBI ODD… Having gone through the roller-coaster over the past one week, with my emotions now settled – I will be (slowly) buying-up in. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious. Created with Sketch. Target our investor community with our suite of Hotcopper Advertising opportunities. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. ASX - Day TradingApril 20 (Reuters) - Invex Therapeutics Ltd (IXC) : MINISTRY OF HEALTH APPROVAL FOR IIH EVOLVE CLINICAL TRIAL IN ISRAELInvestor Presentation, page-2. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. ASX - By Stock. Sentiment for Invex Therapeutics Ltd. **Close price adjusted for splits and dividend and/or capital gain distributions. IXC Valuation Report MST. See page-34. Too many factors to make an educated appraisal of buyout pre-Phase 2 or post Phase 2. 5% last year. Created with Sketch. 64440. . ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Release Date: 21/11/22 08:18; Summary: First Patient Randomised in IIH EVOLVE Phase III Trial; Price Sensitive: Yes; Download Document 205. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. AVALANCHE. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. ASX - By Stock. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. 0 Great. 30 Haven’t supported share price since then on market . ASX - General. 0 Great. Market open. Strong buy side, sell side still very thin. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. , page-2. IXC Price at posting: 23. Also took placement stock @$1. Created with Sketch. , page-4. You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. Latest Posts. About 90 percent of the U. , page-20. Met primary endpoints for phase 2 trials. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. Forums. Notice of Investor Call and Presentation, page-3. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. ASX - Day Trading. Australian finance news, stock quotes, currency information and blogs Active Funds. Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. , page-3. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. Join the HotCopper ASX share market forum today for free. ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. 375,000. 2. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. 8M ! Add to my watchlist. Invex Therapeutics Ltd. ASX - By Stock. Report to HotCopper and itll be the end of it, cheers. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Both approaches can work, but it is not wise to confuse the two. 1. Transparency is our policy. Latest Posts. Some people like to gamble on stocks, others invest. Created with Sketch. Both approaches can work, but it is not wise to confuse the two. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. . ASX - By Stock. Created with Sketch. ASX - Short Term Trading. 79 -0. Below is the broker data for IXC November to. 76 (-1. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - Day TradingI bought some today at 44. . Forums. . Wouldn’t surprised me if they turn this company into something else if he keeps buyingCreated with Sketch. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. 0. Created with Sketch. In the LinkedIn About section for IXC, they list IIH, Acute Stroke and Traumatic Brain Injury. ASX - Day TradingHere's a very good opportunity for people in Sydney. 0¢ Sentiment: Buy Disclosure: HeldHotCopper has news, discussion, prices and market data on GENESIS MINERALS LIMITED. But since the cash holding is double the market cap, there most likely more upside than down side. Appendix 4E and Annual Report, page-3. ASX - Day TradingCreated with Sketch. Charts. US data averaged $2314 per person in direct medical care, the total average direct cost per IIH admission was 4x that or $9256. , page-3. ASX - Day TradingInvex Files Pre-IND/Type B Meeting Request with US FDA, page-2. Withdrawal of AGM Resolutions, page-2. Created with Sketch. LATEST NEWS: Toubani Resources releases MRE update for Kobada gold project, Mali. Share Not unexpected. 0¢ Sentiment: Buy Disclosure: Held. Mernova, a subsidiary of Melodiol Global Health (ASX:ME1), is on track to achieve its highest ever monthly sales, with revenues expected to reach A$891,944 in October 2023. Latest Posts. Notice of Investor Call and Presentation, page-2. Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. ASX - Day Trading. Very impressive. ASX - By Stock. . 20 to $7. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. ASX - Day TradingSomeone bought $500 stock today at 44 cents. Created with Sketch. Market . ASX - Short Term Trading. ASX - By Stock. . ASX - Day Trading. Created with Sketch. ASX - Short Term Trading. 06KBNotification of cessation of securities - IXC. Zillow has 23383 homes for sale in British Columbia. ASX - Day Trading. 8,369 likes · 140 talking about this · 1,407 were here. Created with Sketch. . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-2. What would you like to pay the world leader in IIH science as CSO, and how much of that salary you would expect to be spent on market to buy shares? Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself, Publication of Invex IIH Phase II Pressure Trial Results. . 1 Upvote. Some people like to gamble on stocks, others invest. Created with Sketch. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. When can we expect some update or. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Below is the broker data for IXC November to. It seems a massive hole within the industry of treatment *cough cough* IXC Also surprised by the amount of activity and people who have the disease. I think having this out we can discuss on the way. Created with Sketch. 30 order I had out there for 2-3 weeks. ASX - Day Trading. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. Latest Posts. ASX - Day Trading. ASX - Short Term Trading. . 0. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Proposed Capital Return to Shareholders of $14. Created with Sketch. ASX - Day Trading. ASX - By Stock. ASX - Day TradingCreated with Sketch. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. 5¢ Sentiment: Buy Disclosure: Held Created with Sketch. 1073084. Invex Therapeutics Ltd. 0% $ODM 35. Latest Posts. ASX - General. Plans & Pricing. Slow and steady with IXC. Only took that large seller to sell, now liquidity has dried up and. . ASX - Short Term Trading. IXC below Example of that is NEU Investor Presentation, page-3. It certainly has been a hard few months for the biotech sector with PEB, NYR, NOX and now IXC all having prangs. ASX - Day Trading. . Postcard to ShareholdersIXC (ASX) Ann: Trading Halt - HotCopper. Australia's largest stock trading and investment forum Australia's #1 stock forumIXC peaked at $1. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. Just a matter of time really. IXC Price at posting: 44. Fully funded. Report Created with Sketch. , page-4. Created with Sketch. Latest Posts. ASX - Day Trading. rights. ASX - By Stock. Appendix 4C - quarterly* or having a go at doing so, page-30. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. Andrew Forrest , or his entities have been involved with IXC since inception. Although, IXC is trading about 3-4x lower than what I expect it to be for current stage ($100M-$125M MC aka $75-100M EV) Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. Charts. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-5. 0¢ Sentiment: Buy Disclosure: Held Bumping up this thread as $3. ASX - By Stock. Is it just me or has IXC gone very quiet. ASX - By Stock. Created with Sketch. With a team of 68. , page-3. So your thesis is right on a long time time frame. Jellyroll, arkangel, CD, balkanbroker to name a few have laid out some pretty compelling thesis' on where IXC will be heading. 8 Upvote Created with Sketch. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. Lucky for you all IXC still sits at only 60 cents. Join the HotCopper ASX share market forum today for free. IXC Price at posting. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. ASX - Day TradingIf anyone told me a year ago, "there is a chance IXC cant progress the trial and the management all get sacked" I would agree that there was a chance, but nullified to a 1-2% black swan and worth the upside return profile. Created with Sketch. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. is 19. Invex Files Pre-IND/Type B Meeting Request with US FDAIXC is a long term play mate, not a daytraders plaything as too illiquid. Invex Files Pre-IND/Type B Meeting Request with US FDA IXC is a long term play mate, not a daytraders plaything as too illiquid. . ASX - Day TradingNotice of Webinar & Investor PresentationCreated with Sketch. ASX - By Stock. Latest Posts ForumsThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. To work out how much Presendin is worth, we can look at the costs of IIH to the American health care system. Invex issued US patent for Traumatic Brain Injury. ASX - Day TradingA new thread to put trading comments / reasoning / opinions in. Grabbed my first ever parcel in IXC yesterdy at 80c. ASX - By Stock. 4KB OECCreated with Sketch. Created with Sketch. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . 59pm 09/11/2023 ? HotCopper has news, discussion, prices and market data on INCITEC PIVOT LIMITED. Management have earmarked this a significant milestone - given they previously tied it to performance. Probably been disappointed like all of usCreated with Sketch. ASX - Short Term Trading. Share IXC needs to be proactive and release a statement. . Currency in USD 38. . Created with Sketch. Just another way to saying that we've got Patient 1 out of 240. . Forex. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices.